---
layout: minimal-medicine
title: Factor IX Albumin Fusion Protein Recombinant
---

# Factor IX Albumin Fusion Protein Recombinant
### Generic Name
Factor IX Albumin Fusion Protein Recombinant (rIX-FP)

### Usage

Factor IX Albumin Fusion Protein Recombinant (rIX-FP) is a medication used to treat Hemophilia B, a bleeding disorder caused by a deficiency in Factor IX, a crucial clotting factor in the blood.  Its primary use is to control and prevent bleeding episodes in individuals with Hemophilia B. This includes both on-demand treatment for existing bleeds (such as those in joints, muscles, or internally) and routine prophylactic (preventative) treatment to reduce the frequency of bleeds.  It is also used for perioperative management of bleeding – helping to manage bleeding during and after surgery.  Importantly, rIX-FP is *not* indicated for immune tolerance induction in Hemophilia B patients.  It only replaces Factor IX and is not suitable for replacing other clotting factors.

### Dosage

Dosage of rIX-FP is highly individualized and depends on several factors: the patient's weight, age, the severity of their Hemophilia B, the location and extent of any bleeding, and their individual response to the medication.  Dosages are calculated in International Units (IU) per kilogram (kg) of body weight.  The manufacturer's prescribing information provides detailed calculations and tables, but generally, the goal is to achieve a certain percentage of normal Factor IX levels in the blood.  Here's a summary:

* **Adults and Children:** The dosage differs primarily in the expected increase in circulating Factor IX levels per IU/kg. Children under 12 see a 1 IU/dL increase, while those 12 and older see a 1.3 IU/dL increase per IU/kg. Dosage is adjusted based on the bleeding severity: minor bleeds require lower target Factor IX levels than major bleeds.  Prophylactic doses are different again and aim for consistent levels to prevent bleeding. The World Federation of Hemophilia (WFH) guidelines are often used to guide treatment choices.

* **Forms:** rIX-FP is administered intravenously (IV) only.

* **Administration:** The medication is reconstituted (mixed with sterile water) before administration.  The infusion rate should be adjusted for patient comfort, typically not exceeding 10 mL/min.  It's administered at room temperature.

Specific dosage recommendations for different bleeding situations (minor, major, joint bleeds, surgery etc.) and for prophylaxis are complex and are best determined in consultation with a healthcare professional and following the medication's prescribing information.

### Side Effects

Common side effects (occurring in ≥2% of patients) may include headache.  Less common side effects (<1%) include dizziness, skin rash, eczema, and hypersensitivity reactions.

Serious but less common side effects include the development of neutralizing antibodies (inhibitors) against Factor IX, thromboembolism (blood clots), and nephrotic syndrome.

**If you experience any adverse effects, especially serious ones, consult your healthcare provider immediately.**

### How it Works

rIX-FP is a recombinant (genetically engineered) protein that works by replacing the missing Factor IX in individuals with Hemophilia B.  The medication is a fusion protein of Factor IX and albumin. The albumin component extends the half-life of Factor IX in the bloodstream, meaning it stays active longer, requiring fewer administrations. By restoring Factor IX levels, rIX-FP helps the blood to clot properly, preventing and controlling bleeding.


### Precautions

* **Contraindications:** rIX-FP is contraindicated in patients with a history of life-threatening hypersensitivity reactions to the medication or its components.

* **Interactions:**  While specific drug interactions are not extensively listed, it is crucial to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and herbal supplements.

* **Warnings:** There is an increased risk of hypersensitivity reactions (including anaphylaxis), formation of inhibitors to Factor IX, thromboembolism, and nephrotic syndrome.  Use caution in patients with hepatic (liver) disease.  Pregnant and breastfeeding women should discuss the use of rIX-FP with their healthcare provider.

* **Special Populations:** Dosage adjustments for patients with renal impairment, hepatic impairment, or obesity may be necessary and should be determined on a case-by-case basis in consultation with a healthcare professional.

### FAQs

* **Q: How is rIX-FP stored?** A: Refer to the product packaging for specific storage instructions.  Generally, it requires refrigeration.

* **Q: How long does rIX-FP take to work?** A:  The onset of action depends on the infusion rate and individual patient factors.  Factor IX levels typically reach their peak within 15-30 minutes of infusion.

* **Q: What should I do if I miss a dose of prophylactic rIX-FP?** A: Consult your healthcare provider immediately to determine the best course of action.

* **Q: Can I drink alcohol while taking rIX-FP?** A: Consult your healthcare provider; there's no specific information about alcohol interaction, but it's always best to discuss such issues with your doctor.

* **Q: What if I develop an allergic reaction?** A: Stop the infusion immediately and seek immediate medical attention.

**Disclaimer:** This information is for educational purposes only and should not be considered medical advice.  Always consult with a healthcare professional for diagnosis and treatment of any medical condition.  Refer to the official prescribing information for the most accurate and up-to-date details regarding rIX-FP.
